Trial Profile
Clinical study of oral palifosfamide for the treatment of solid tumours
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 25 Aug 2022
Price :
$35
*
At a glance
- Drugs Palifosfamide (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Alaunos Therapeutics